Thus, this system might be likely to reflect the activation of endogenous Rac1 mainly in the patients’ tumor tissues, although activation of other Rac members, such as Rac2 and Rac3 and/or Cdc42 cannot be ruled out. This evidence concerns the gene RAC2 and neoplasm.